Cisplatin synergizes immune checkpoint blocking through RNFT1 mediated PD-L1 recycling in Triple Negative Breast Cancer

被引：0
|
作者：
Chu, Jiahui
Zhang, Yifan
Hua, Yijia
Gong, Jue
Mei, Jie
Fu, Ziyi
Yi, Yongmei
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-24-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-24-03
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combined immunotherapy for metastatic triple-negative breast cancer based on PD-1/PD-L1 immune checkpoint blocking
    He, Rui
    Yuan, Xing
    Chen, Zeran
    Zheng, Yongfeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [2] Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Hongshu Li
    Ying Chang
    Tiefeng Jin
    Meihua Zhang
    Cancer Cell International, 25 (1)
  • [3] Effects of Cardamonin on PD-1/PD-L1 Checkpoint in Triple-Negative Breast Cancer
    Mendonca, Patricia
    Hill, Lonnie
    Soliman, Karam F. A.
    FASEB JOURNAL, 2022, 36
  • [4] Association PD-L1 overexpression with immune checkpoint inhibitor effect in triple-negative breast cancer
    Park, A. Young
    Kim, Ju Hee
    Lee, Sangen
    Kim, Hong Kyu
    Lee, Han-Byoel
    Han, Wonshick
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer
    Bullock, Kennady K.
    Richmond, Ann
    CANCERS, 2024, 16 (12)
  • [6] PD-L1 testing in triple negative breast cancer
    Dobritoiu, F.
    Chefani, A.
    Billingham, K.
    Chenard, M.
    Vaziri, R.
    Lacroix-Triki, M.
    Waydelich, A.
    Erb, G.
    Toro, P.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2019, 475 : S17 - S18
  • [7] The immune checkpoint PD-L1 alters choline kinase expression and metabolism in triple negative breast cancer cells
    Pacheco-Torres, Jesus
    Penet, Marie-France
    Wildes, Flonne
    Mironchik, Yelena
    Krishnamachary, Balaji
    Bhujwalla, Zaver M.
    CANCER RESEARCH, 2020, 80 (16)
  • [8] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [9] Effect of AURKA targeting on nuclear PD-L1 and the efficacy of immune checkpoint inhibitors in triple-negative breast cancer
    Takchi, Andrew
    D'assoro, Antonino Bonaventura, Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy
    Wang, Zhiren
    Cordova, Leyla Estrella
    Chalasani, Pavani
    Lu, Jianqin
    MOLECULAR PHARMACEUTICS, 2022, 19 (12) : 4665 - 4674
12345